This is a demonstration of our report format, built on a fictional test patient. Nothing here is medical advice.
Controlled · General practitioner's report
Your health picture at a glance
Summary
- Your blood sugar (HbA1c) has been above the lab reference in all five measurements since 2022 — and the most recent value went up, not down.
- HbA1c was checked about once a year; for diagnosed type 2 diabetes, the standard is at least twice a year.
- You told us you started Ozempic to lose weight. A 2023 visit note says your mother had medullary thyroid cancer — and that family history is on the list of cases where Ozempic's FDA label says it must not be used.
- Two things are missing from your records entirely: blood pressure measurements and thyroid lab tests. Both are worth a question at your next visit.
What deserves attention
Blood sugar — the trend and its freshest point
What we see
| date | HbA1c, % | flag | anchor |
|---|---|---|---|
| 2022-04-12 | 9.1 | H | [m:1] |
| 2023-05-20 | 8.2 | H | [m:3] |
| 2024-06-03 | 7.4 | H | [m:4] |
| 2025-02-17 | 6.9 | H | [m:6] |
| 2026-01-22 | 7.2 | H | [m:8] |
All five values are above the lab reference (4.0–6.0%). The gaps between tests were 9–13 months. The most recent value rose: 7.2 after 6.9 — we show the full series deliberately, including the point that spoils the story of steady improvement.
Why it matters
For diagnosed type 2 diabetes, current guidance recommends checking glycemic status at least twice a year, and more often when goals aren't met.1
What to ask your doctor
“How often should my HbA1c be checked — and does the recent rise from 6.9 to 7.2 change anything in my plan?”
Ozempic and your family history
What we see
In the questionnaire you told us you started Ozempic this year, prescribed through an online weight-loss service. A visit note dated 2023-09-14 lists your family history: “Mother — medullary thyroid carcinoma” [n:2].
Why it matters
Ozempic's label opens with a boxed warning, the FDA's most serious kind, and it says: “OZEMPIC is contraindicated in patients with a personal or family history of MTC.”2 In plain words: people who have had medullary thyroid cancer (MTC), or whose family has, should not take it. An online prescriber sees only what you tell them — this note sits in a record they may never have seen.
What to ask your doctor
“My mother had medullary thyroid cancer. Is Ozempic safe for me — and if not, what are my options for losing weight?”
What's missing from your records
- Blood pressure — no measurements anywhere in the archive. A blood-pressure medication (losartan) was prescribed and later stopped, yet not a single reading made it into your records. Worth asking: were readings taken at appointments, and can they be added?
- Thyroid lab tests — none found. An ultrasound conclusion from 2026-03-05 mentions your thyroid [n:1], but there are no thyroid blood tests (TSH, free T4) in the archive. Worth asking: are thyroid labs worth doing?
Your medications
| medication | status | label notes |
|---|---|---|
| Metformin | taking | see your medication brief |
| Ozempic (semaglutide) | taking (you told us; prescribed online this year) | boxed warning: see “Ozempic and your family history” |
| Losartan 50 mg | stopped by your doctor in March | see your medication brief |
Questions for your doctor
- How often should my HbA1c be checked, given the values above the reference — and does the recent rise change my plan?
- My mother had medullary thyroid cancer — is Ozempic safe for me, and if not, what else could help me lose weight?
- Were blood pressure readings taken when losartan was prescribed and stopped — and can they be added to my records?
- Are thyroid lab tests worth doing, given the ultrasound note?
What we checked — and what we couldn't
This report is built only from the documents provided: 7 studies and 12 measurements, 2022–2026. Tests done elsewhere are invisible to us, and their absence here proves nothing. In this trial run the patient's age and sex were withheld, so age-specific screening rules are flagged as questions rather than applied. This is not a diagnosis and not a prescription — it is material for a conversation with your doctor.
Source note 1: ADA Standards of Care 2026, Glycemic Goals. Source note 2: FDA prescribing information for Ozempic (semaglutide) injection — Boxed Warning; section 4, Contraindications. Full citations, with editions and quotes, are listed in the appendix of a real report.